Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Production Started

Corona Remedies Production Started

Corona Remedies commenced commercial production at its EU-GMP approved Women's Hormone facility. The plant has an annual capacity of 194 million tablets/capsules.

Source

BSE filing, NSE: CORONA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Corona Remedies Ltd: key numbers

Share price
₹2,149.60
Market cap
₹13,147 Cr
Revenue (annual)
₹1,403 Cr
Net profit (annual)
₹185.1 Cr
P/E (TTM)
66.1×Sector 45.9×
Promoter holding
69.00%+0.00% QoQ
FII holding
4.21%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Corona Remedies Ltd

All →

Other production started announcements

All →